Documents ©2014 MFMER | slide-1 Survivorship for “cured” Hodgkin patients – How should we be following....

Slide 1©2014 MFMER | slide-1 Survivorship for “cured” Hodgkin patients – How should we be following them? Carrie Thompson, MD Mayo Clinic Lymphoma & Myeloma 2014…

Documents Non-pegylated liposomial doxorubicin is less cardiotoxic than epirubicin in women with breast...

Slide 1Non-pegylated liposomial doxorubicin is less cardiotoxic than epirubicin in women with breast cancer: evidence from the LITE randomized study Giuseppe Biondi Zoccai,…

Documents Giuseppe Biondi Zoccai, MD University of Modena and Reggio Emilia gbiondizoccai@gmail

Non-pegylated liposomial doxorubicin is less cardiotoxic than epirubicin in women with breast cancer: evidence from the LITE randomized study Giuseppe Biondi Zoccai, MD University…